Exicure, Inc. (XCUR)
NASDAQ: XCUR · Real-Time Price · USD
6.00
+0.16 (2.74%)
Dec 24, 2025, 1:00 PM EST - Market closed
Exicure Market Cap
Exicure has a market cap or net worth of $38.24 million as of December 24, 2025. Its market cap has decreased by -36.90% in one year.
Market Cap
38.24M
Enterprise Value
34.17M
1-Year Change
-36.90%
Ranking
Category
Stock Price
$6.00
Market Cap Chart
Since May 22, 2018, Exicure's market cap has decreased from $122.31M to $38.24M, a decrease of -68.73%. That is a compound annual growth rate of -14.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 38.24M | -7.94% |
| Dec 31, 2024 | 41.54M | 727.79% |
| Dec 29, 2023 | 5.02M | -12.10% |
| Dec 30, 2022 | 5.71M | -72.06% |
| Dec 31, 2021 | 20.44M | -86.82% |
| Dec 31, 2020 | 155.05M | -37.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 22, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 959.53B |
| Johnson & Johnson | 495.78B |
| AbbVie | 404.36B |
| UnitedHealth Group | 294.22B |
| AstraZeneca | 287.19B |
| Novartis AG | 267.64B |
| Merck & Co. | 260.71B |
| Novo Nordisk | 232.28B |